APA (7th ed.) Citation

Ehinger, E., Darabi, A., Visse, E., Edvardsson, C., Tomasevic, G., Cederberg, D., . . . Siesjö, P. (2025). Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: Study protocol for a randomized double-blind placebo-controlled trial. Trials, 26(1), 1. https://doi.org/10.1186/s13063-025-08792-z

Chicago Style (17th ed.) Citation

Ehinger, Erik, et al. "Antisecretory Factor as Add-on Treatment for Newly Diagnosed Glioblastoma, IDH Wildtype: Study Protocol for a Randomized Double-blind Placebo-controlled Trial." Trials 26, no. 1 (2025): 1. https://doi.org/10.1186/s13063-025-08792-z.

MLA (9th ed.) Citation

Ehinger, Erik, et al. "Antisecretory Factor as Add-on Treatment for Newly Diagnosed Glioblastoma, IDH Wildtype: Study Protocol for a Randomized Double-blind Placebo-controlled Trial." Trials, vol. 26, no. 1, 2025, p. 1, https://doi.org/10.1186/s13063-025-08792-z.